Satish Arakeri

Immunohistochemical Expression of Programmed Death Ligand 1 (PD-L1) and Its Correlation with Clinicopathological Parameters in Breast Carcinoma

Monika Pawar & Satish Arakeri · Asian Oncology Research Journal · 2025

Aims: Breast carcinoma (BC) is the leading cause of tumor burden, with an incidence of 11.8%. The programmed cell death protein 1(PD-1)/programmed death ligand 1 (PD-L1) pathway represents an adaptive immune resistance mechanism that tumor cells exert. Recent updates in the treat...

Open access Research Article 10.9734/aorj/2025/v8i1108

Role of Immunohistochemistry in a Rare Case of Undifferentiated Soft Tissue Sarcoma with Cytohistopathological Correlation

Mamatha K., Kezia Anna Jacob, Satish Arakeri & Manjunath Kotennavar · Asian Journal of Case Reports in Surgery · 2025

Soft tissue sarcomas (STS) constitute a rare subset of malignancies, posing diagnostic challenges due to their varied clinical and histopathological presentations. This case report describes a young adult female who presented with a rapidly growing thigh mass initially misinterpr...

Open access Research Article 10.9734/ajcrs/2025/v8i2673